implant surgery. ?
Conditions
Interventions
Intervention 1: Intervention group 1:Ibuprofen 400 milligram tablet, immediately after the surgery and every 8 hours for 2 days. Intervention 2: Intervention group2: Novafen capsule (containing acetam
Treatment - Drugs
Intervention group 1:Ibuprofen 400 milligram tablet, immediately after the surgery and every 8 hours for 2 days
Intervention group2: Novafen capsule (containing acetaminophen 325 mg, ibuprofen 200 mg and caffeine 40 mg) immediately after the surgery and every 8 hours for 2 days
Control group: Acetaminofen 500 miligram tablet, immediately after the surgery and every 8 hours for 2 days
Sponsors
Vice Chancellor for Research of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria of the study: Informed consent for being included in the study; Candidate patients of implant surgery aged 18?40 years; The hard and soft tissue region should be favorable for implant; Implant replacement without any adjunctive surgery Exclusion criteria of the study: Suffering from a systemic disease; Addictions to alcohol or smoking or every psychotropic substance; Diagnosed sensitivity to NSAIDs, Caffeine or Acetaminophen; Consuming drugs interfering with Ibuprofen, Novafen or Acetaminophen; Receiving any type of analgesics at least four hours before implant surgery
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Relief after implant surgery. Timepoint: 3h,12h, 24h and 48h after implant surgery. Method of measurement: VAS( Visual Analgesic Scale) 3h after implant surgery; VRS( Verbal Rating Scale) 12h,24h and 48h after implant surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Zarandi
Department of Periodontics of Dental Faculty of Tabriz University of Medical Sciences
Outcome results
None listed